Posted by: Georgia Retina in News, Uncategorized
Dr. David Chin Yee’s article was published on October 2015 in the British journal of Ophthalmology which compared the 2 most common treatment regimens for the treatment of Wet Age Related Macular Degeneration (Wet AMD).
The article explains that treatment for Wet AMD has continued to place a huge burden on patients, care takers, and treating physicians. With most Retina specialists adapting regimens to reduce this burden by trying to decrease the number of injections or visits needed to control and treat Wet AMD. The two most common regimens that have been shown to be effective and practiced are “as needed” (patients follow up monthly and receiving treatment or observed as determined on examination) or “treat and extend” (patients always receive treatment at visits, but interval for return may be extended or shortened determined on examination).
In Dr. Chin Yee’s study he analyzed studies implementing both regimens and compared the efficacy between the two and determined based on his analysis that the treat and extend regimen provided superior outcomes to the as needed regimen.
The study results will serve as a guide for other treating physicians to transition to a treat and extend regimen, which will help to reduce the treatment burden on patients and their care takers in addition to providing optimal visual outcomes.
Georgia Retina’s physicians are continually committed to advancing research into treatments for diseases of the retina, and are often consulted by the media for their insight into new therapies.
Dr. Sharma, a board-certified ophthalmologist, graduated with honors in Biomedical Engineering from the University of Miami, before continuing on to the University of Miami Miller School of Medicine. His ophthalmology residency at the Henry Ford Hospital in Detroit, MI was distinguished by his appointment as Chief Resident. Dr. Chin Yee completed a two-year vitreoretinal fellowship at the Washington University in St. Louis, one of the premier fellowship programs in the nation. He has been an active participant in a number of clinical studies, and his publications have appeared in prominent medical journals.
At Georgia Retina, patients’ vision needs are the top priority. As one of the largest retina-only medical practices in the southeastern United States, Georgia Retina specializes in treating diseases of the retina, macula, and vitreous. Its thirteen board-certified ophthalmologists have received special Fellowship training in vitreo-retinal diseases and surgery, and are engaged in clinical trials with the goal of advancing research into retinal diseases, their causes, and their cures.
